FDA orders Juul to stop selling its vaping products in the U.S.

The axe has fallen for e-cigarette maker Juul.

The FDA ordered the company to stop selling and distributing its ubiquitous vaping devices in the U.S. Thursday, a dramatic end for a company that dominated the e-cigarette market and was valued at $38 billion at the top of its game.

Juul will no longer be able to sell its vapes nor its 5 percent or 3 percent tobacco and menthol-flavored pods in the U.S. without “risk[ing] enforcement action” from the U.S. Food and Drug Administration. Retailers will also be prohibited from stocking Juul products in the U.S.

The FDA’s ban against Juul come after the company failed to provide consistent evidence about the safety of its vapes and tobacco pods.

“As with all manufacturers, JUUL had the opportunity to provide evidence demonstrating that the marketing of their products meets these standards,” Acting Director of the FDA’s Center for Tobacco Products Michele Mital said. “However, the company did not provide that evidence and instead left us with significant questions.”

The FDA clarifies that its actions don’t directly restrict individual possession or use of Juul products, though obtaining the company’s vapes and pods is about to be much more difficult for U.S.-based users.

Regulatory woes had already cut deeply into the company’s valuation, but the FDA’s actions spell outright doom for its U.S. operations. Juul competitors Reynolds American and NJOY Holdings previously received authorization and will be allowed to continue selling their own products, though the FDA maintains that tobacco is harmful and addictive even when vaped.

This article was originally published on TechCrunch.com. Read More on their website.